/Companies

Verdiva Bio

77 employees on LinkedIn · 4 known investors

Find your way into Verdiva Bio

Each arrow is one introduction. Sign up to fill in the first one.

237 people can intro you to Jane

Ask Wouter Joustra to introduce you to Jane Hughes

You →Wouter · together at Verdiva Bio →Jane

Sign up to find every way you can get introduced to Verdiva Bio

  • Your email: who you already know at Verdiva Bio, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Verdiva Bio team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.

Founders & leadership

JHJane Hughes
Jane HughesChief Scientific OfficerChief Scientific Officer of Verdiva Bio, Jane Hughes has expertise in drug development, translational research, and scientific domains including immunology, inflammation, neuroscience, and cell biology.
KFKhurem Farooq
Khurem FarooqChief Executive Officer

Investors · 4

Funding

SEC filings, press & company announcements

$410M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Verdiva Bio do?
Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
Who are Verdiva Bio's investors?
Verdiva Bio's investors include OrbiMed, RA Capital, Forbion, General Atlantic.
How much funding has Verdiva Bio raised?
Verdiva Bio has disclosed $410M raised across 1 round.